Hsbc Holdings PLC lifted its holdings in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 1,355.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 185,155 shares of the technology company’s stock after acquiring an additional 172,435 shares during the period. Hsbc Holdings PLC’s holdings in Novanta were worth $21,964,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Invesco Ltd. grew its position in Novanta by 9.0% during the 4th quarter. Invesco Ltd. now owns 68,089 shares of the technology company’s stock worth $8,102,000 after purchasing an additional 5,600 shares during the last quarter. Corient Private Wealth LLC purchased a new position in shares of Novanta during the fourth quarter worth about $275,000. Alberta Investment Management Corp acquired a new position in Novanta in the 4th quarter valued at about $1,285,000. Mercer Global Advisors Inc. ADV purchased a new stake in Novanta during the 4th quarter valued at approximately $314,000. Finally, Empowered Funds LLC raised its stake in Novanta by 16.7% during the 4th quarter. Empowered Funds LLC now owns 7,888 shares of the technology company’s stock valued at $939,000 after acquiring an additional 1,128 shares during the last quarter. Hedge funds and other institutional investors own 98.35% of the company’s stock.
Insiders Place Their Bets
In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the completion of the transaction, the chief executive officer directly owned 42,761 shares of the company’s stock, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.
Analyst Ratings Changes
View Our Latest Research Report on Novanta
Novanta Price Performance
Novanta stock opened at $152.00 on Thursday. The company has a market cap of $5.41 billion, a P/E ratio of 110.15 and a beta of 1.68. Novanta Inc. has a one year low of $98.27 and a one year high of $171.85. The business has a fifty day moving average of $148.44 and a two-hundred day moving average of $135.14. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.69 and a current ratio of 3.56.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. The business had revenue of $257.71 million for the quarter, compared to analysts’ expectations of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, analysts predict that Novanta Inc. will post 3.59 earnings per share for the current fiscal year.
About Novanta
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Read More
- Five stocks we like better than Novanta
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
